Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

STOX1 promotor region -922 T > C polymorphism is associated with Early-Onset preeclampsia.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology - 1 Nov 2022

Akin Seyda, Pinarbasi Ergun, Bildirici Aslihan Esra, Cekin Nilgun

Abstract excerpt

Preeclampsia (PE), affecting 5-8% of pregnancies, is a common pregnancy disease that has harmful effects on mother and foetus. It has been found that the STOX1 (Storkhead Box 1), which is a transcription factor, carries variants associated with PE. Previous studies showed that, there was a strong relationship between PE and STOX1 variants. Therefore, we hypothesised that variants in the promoter region of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation

Share to Polymorphism, Genetic

Share to Pre-Eclampsia

Share to Pregnancy

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 36369889
DOI: 10.1080/01443615.2022.2141612

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

STOX1 promotor region -922 T > C polymorphism is associated with Early-Onset preeclampsia.PMID 36369889Read ↗

STOX1: Key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation.Semantic proximity Read ↗

Targeting STOX1 in the therapy of preeclampsia.Semantic proximity Read ↗

Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample.Semantic proximity Read ↗

Association of <em>STOX1</em> Maternal and Fetal Polymorphisms with Hypertensive Disorders of Pregnancy: Preliminary Evidence for a Parent-of-Origin Effect and Maternal-Fetal Genotypic InteractionSemantic proximity Read ↗

Re-evaluation of the role of STOX1 transcription factor in placental development and preeclampsia.Semantic proximity Read ↗

Genetic aspects of preeclampsia.Semantic proximity Read ↗

STOX1 is not imprinted and is not likely to be involved in preeclampsiaSemantic proximity Read ↗

STOX1 deficiency is associated with renin-mediated gestational hypertension and placental defectsSemantic proximity Read ↗

Functional Evaluation of STOX1 (STORKHEAD-BOX PROTEIN 1) in Placentation, Preeclampsia, and Preterm Birth.Semantic proximity Read ↗

Genetic Approaches in Preeclampsia.Semantic proximity Read ↗

Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsiaSemantic proximity Read ↗

Molecular Mechanisms of Trophoblast Dysfunction Mediated by Imbalance between STOX1 IsoformsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.